$BSX Cashflow Statement | Understand Stock

$BSX

$45.58 -$0.11 (0.24%) Close

$BSX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net income (loss)
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities
Loss (gain) on disposal of businesses and assets
Depreciation and amortization
Deferred and prepaid income taxes
Stock-based compensation expense
Goodwill and other intangible asset impairment charges
Net loss (gain) on investments and notes receivable
Contingent consideration net expense (benefit)
Inventory step-up amortization
Debt extinguishment net charges
Fixed asset and right-of-use asset impairment
Other, net
Increase (decrease) in operating assets and liabilities, excluding purchase accounting:
Trade accounts receivable
Inventories
Other assets
Accounts payable, accrued expenses and other liabilities
Cash provided by (used for) operating activities
Investing Activities
Purchases of property, plant and equipment and internal use software
Proceeds from sale of property, plant and equipment
Payments for acquisitions of businesses, net of cash acquired
Payments for investments and acquisitions of certain technologies
Proceeds from disposal of certain businesses and assets
Other, net
Proceeds from settlements of hedge contracts
Cash provided by (used for) investing activities
Financing Activities
Payment of contingent consideration previously established in purchase accounting
Payments for royalty rights
Proceeds from royalty rights transfer
Payments for finance leases
Payments on short-term borrowings
Proceeds from short-term borrowings, net of debt issuance costs
Net increase (decrease) in commercial paper
Payments on borrowings from credit facilities
Proceeds from borrowings on credit facilities
Payments on long-term borrowings and debt extinguishment costs
Proceeds from long-term borrowings, net of debt issuance costs
Cash dividends paid on preferred stock
Net proceeds from issuance of preferred stock in connection with public offering
Net proceeds from issuance of common stock in connection with public offering
Payments for repurchase of common stock
Cash used to net share settle employee equity awards
Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans
Other, net
Cash provided by (used for) financing activities

Effect of foreign exchange rates on cash
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period
Supplemental Information
Cash paid for income taxes, net
Cash paid for interest
Fair value of contingent consideration recorded in purchase accounting
Non-cash impact of transferred royalty rights
Noncash transactions related to finance lease obligations
Purchase of Property, plant and equipment, net through exchange of right-of-use assets
Cash and cash equivalents
Restricted cash and restricted cash equivalents included in Other current assets
Restricted cash equivalents included in Other long-term assets

Comments